Design Therapeutics, Inc.
DSGN
$4.72
-$0.24-4.84%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 245.48M | 254.07M | 261.02M | 270.69M | 281.80M |
| Total Receivables | 1.26M | 1.18M | 1.40M | 1.68M | 1.43M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.30M | 1.99M | 2.43M | 1.52M | 1.35M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 248.04M | 257.24M | 264.84M | 273.89M | 284.58M |
|
|
|||||
| Total Current Assets | 248.04M | 257.24M | 264.84M | 273.89M | 284.58M |
| Net Property, Plant & Equipment | 3.63M | 3.96M | 4.31M | 4.48M | 4.63M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 427.00K | 427.00K | 429.00K | 427.00K | 430.00K |
| Total Assets | 252.09M | 261.63M | 269.58M | 278.79M | 289.64M |
|
|
|||||
| Total Accounts Payable | 2.19M | 1.47M | 1.30M | 1.37M | 1.94M |
| Total Accrued Expenses | 5.48M | 5.18M | 4.34M | 4.99M | 6.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 800.00K | 778.00K | 757.00K | 736.00K | 716.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.46M | 7.43M | 6.39M | 7.09M | 9.62M |
|
|
|||||
| Total Current Liabilities | 8.46M | 7.43M | 6.39M | 7.09M | 9.62M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.53M | 1.74M | 1.95M | 2.14M | 2.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.00M | 9.18M | 8.34M | 9.24M | 11.96M |
|
|
|||||
| Common Stock & APIC | 468.84M | 465.10M | 461.98M | 458.46M | 455.25M |
| Retained Earnings | -227.21M | -213.56M | -200.52M | -188.73M | -177.63M |
| Treasury Stock & Other | 475.00K | 914.00K | -217.00K | -167.00K | 62.00K |
| Total Common Equity | 242.10M | 252.45M | 261.24M | 269.56M | 277.69M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 242.10M | 252.45M | 261.24M | 269.56M | 277.69M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 242.10M | 252.45M | 261.24M | 269.56M | 277.69M |
|
|
|||||
